NINDS announces its intent to soon publish two funding opportunities. This early notice will allow potential applicants sufficient time to develop meaningful collaborations and responsive projects.
One new initiative will solicit applications for hypothesis-driven clinical research studies that will accelerate and augment the discovery of biomarkers as a component of the NINDS Parkinson’s Disease Biomarkers Identification Network (PD-BIN). The announcement is expected to be published in late spring 2011 with a receipt date in fall 2011. For more information contact Dr. Katrina Gwinn, program director, Neurogenetics Cluster, NINDS, at email@example.com or 301-496-5745.
The other funding opportunity will promote the continued development of publically available, well characterized, induced pluripotent stem cell research resources. These resources will encourage collaborative research among investigators and ultimately accelerate basic science discoveries and therapeutic development for late-onset neurodegenerative disorders. The announcement is expected to be published in spring 2011 with a receipt date in early summer 2011. For more information contact Dr. Margaret Sutherland, program director, Neurodegeneration Cluster, NINDS, at firstname.lastname@example.org or 301-496-9531.